Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

By afschroeder • March 14, 2026

Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot GE, Brinson C, Buchbinder S, Molina JM, Gravett RM, Brock JB, Ramgopal MN, Rosengren AL, Ofotokun I, Valdez Madruga J, Liegeon G, Panchia R, Supparatpinyo K, Avihingsanon A, Creticos C, Swaminathan S, Doblecki-Lewis S, Rodriguez J, Siegel M, Oka S, Puthanakit T, Grinsztejn B, Sanders EJ, Lama JR, Lombaard J, Ndlovu N, Hwang P, Du J, Jackson B, Homony B, Evans B, Sklar P, Robertson MN, Plank RM. Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. Clin Infect Dis. 2026 Mar 14:ciag171. doi: 10.1093/cid/ciag171. Epub ahead of print. PMID: 41830344.

Tags: cisgender men, HIV-1 prevention, Infectious Diseases, islatravir, PrEP, Publications, Transgender women

Parvovirus B19 Infection Presenting as Acute Anemia and Polyarthropathy

Young P, Beaird OE. Parvovirus B19 Infection Presenting as Acute Anemia and Polyarthropathy. Cureus. 2026 Mar 4;18(3):e104656. doi: 10.7759/cureus.104656. PMID: 41939592; PMCID: PMC13048235.

Low Preoperative Platelet Count Is Associated With Deep Surgical Site Infection in Knee Arthroplasty

Brown JM, Lloyd TS, Eusebio M, Golzar A, Li A, Mehany J, Chun RF, Adams JS, Yeaman MR, McPherson EJ, Bernthal NM. Low Preoperative Platelet[...]

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu[...]